Use of Nutritional Supplements to Increase the Efficacy of Fluoxetine in the Treatment of Anorexia Nervosa

International Journal of Eating Disorders

Volumn 35, Issue 1, 2004, Pages 10-15

  Barbarich, Nicole C ^a   McConaha, Claire W ^a   Halmi, Katherine A ^b   Gendall, Kelly ^a   Sunday, Suzanne R ^b   Gaskill, Jill ^a   La Via, Maria ^a   Frank, Guido K ^a   Brooks, Sarah ^a   Plotnicov, Katherine H ^a   Kaye, Walter H ^a,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Anorexia nervosa; Fluoxetine; Nutritional supplements

Indexed keywords

FLUOXETINE; MINERAL; PLACEBO; TRYPTOPHAN; VITAMIN;

ADOLESCENT; ADULT; ANOREXIA NERVOSA; ANXIETY DISORDER; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; HUMAN; NUTRITIONAL SUPPORT; NUTRITIONAL VALUE; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; UNDERWEIGHT; WEIGHT GAIN;

ADULT; ANOREXIA NERVOSA; COMBINED MODALITY THERAPY; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; DOUBLE-BLIND METHOD; EICOSANOIC ACIDS; FEMALE; FISH OILS; FLUOXETINE; HUMANS; NUTRITION THERAPY; SEROTONIN UPTAKE INHIBITORS; TRYPTOPHAN; VITAMINS;

EID: 9144219626     PISSN: 02763478     EISSN: None     Source Type: Journal    
DOI: 10.1002/eat.10235     Document Type: Article

References (30)

1. Alderdice, J.T., Dinsmore, W.W., Buchanan, K.D., & Adams, C. (1985). Gastrointestinal hormones in anorexia nervosa. Journal of Psychiatric Research, 19, 207-213.
2. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
3. Anderson, I.M., Parry-Billings, M., Newsholme, E.A., Fairburn, C.G., & Cowen, P.J. (1990). Dieting reduces plasma tryptophan and alters brain 5-HT function in women. Psychological Medicine, 20, 785-791.
4. Attia, E., Haiman, C., Walsh, B.T., & Flater, S.R. (1998). Does fluoxetine augment the inpatient treatment of anorexia nervosa? American Journal of Psychiatry, 155, 548-551.
5. Coppen, A., Swade, C., Jones, S.A., Armstrong, R.A., Blair, J.A., & Leeming, R.J. (1989). Depression and tetrahydrobiopterin: The folate connection. Journal of Affective Disorders, 16, 103-107.
6. Ferguson, C.P., La Via, M.C., Crossan, P.J., & Kaye, W.H. (1999). Are serotonin selective reuptake inhibitors effective in underweight anorexia nervosa? International Journal of Eating Disorders, 25, 11-17.
7. Fernstrom, J.D., & Wurtman, R.J. (1971). Brain serotonin content: Increase following ingestion of carbohydrate diet. Science, 174, 1023-1025.
8. Frank, G.F., Kaye, W.H., Meltzer, C.C., Price, J.C., Greer, P., McConaha, C., & Skovira, K. (2002). Reduced 5-HT2A receptor binding after recovery from anorexia nervosa. Biological Psychiatry, 52, 896-906.
9. Frost, R.O., Marten, P., Lahart, C., & Rosenblate, R. (1990). The dimensions of perfectionism. Cognitive Therapy and Research, 14, 449-468.
10. Goodman, W.K., Price, L.H., Rasmussen, S.A., Mazure, C., Fleischmann, R.L., Hill, C.L., Heninger, G.R., & Chamey, D.S. (1989). The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Archives of General Psychiatry, 46, 1006-1011.
11. Goodwin, G.M., Fairbum, C.G., & Cowen, P.J. (1987). The effects of dieting and weight loss on neuroendocrine responses to tryptophan, clonidine, and apomorphine in volunteers. Important implications for neuroendocrine investigations in depression. Archives of General Psychiatry, 44, 952-957.
12. Herzog, D.B., Nussbaum, K.M., & Marmor, A.K. (1996). Comorbidity and outcome in eating disorders. Psychiatric Clinics of North America, 19, 843-859.
13. Huether, G., Zhou, D., & Ruther, E. (1997). Long-term modulation of presynaptic 5-HT-output: Experimentally induced changes in cortical 5-HT-transporter density, tryptophan hydroxylase content and 5-HT innervation density. Journal of Neural Transmission General Section, 104, 993-1004.
14. Kaye, W.H., Ebert, M.H., Raleigh, M., & Lake, R. (1984). Abnormalities in CNS monoamine metabolism in anorexia nervosa. Archives of General Psychiatry, 41, 350-355.
15. Kaye, W.H., G.K., F., Meltzer, C.C., Price, J., Drevets, W.C., & Mathis, C. (2003). Enhanced pre- and postsynaptic 5HT1A receptor binding after recovery from anorexia nervosa: Relationship to anxiety and harm avoidance. Manuscript submitted for publication.
16. Kaye, W.H., Gwirtsman, H.E., George, D.T., & Ebert, M.H. (1991). Altered serotonin activity in anorexia nervosa after long-term weight restoration. Does elevated cerebrospinal fluid 5-hydroxyindoleacetic acid level correlate with rigid and obsessive behavior? Archives of General Psychiatry, 48, 556-562.
17. Kaye, W.H., Nagata, T., Weltzin, T.E., Hsu, L.K., Sokol, M.S., McConaha, C., Plotnicov, K.H., Weise, J., & Deep, D. (2001). Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa. Biological Psychiatry, 49, 644-652.
18. Kumai, M., Tamai, H., Fujii, S., Nakagawa, T., & Aoki, T.T. (1988). Glucagon secretion in anorexia nervosa. American Journal of Clinical Nutrition, 47, 239-242.
19. McClain, C., Stuart, M., Kasarskis, E., & Humphries, L. (1993). Zinc, appetite regulation and eating disorders. Progress in Clinical and Biological Research, 380, 47-64.
20. McKenzie, J.M., & Joyce, P.R. (1992). Hospitalization for anorexia nervosa. International Journal of Eating Disorders, 11, 235-241.
21. Mira, M., Stewart, P.M., & Abraham, S.F. (1989). Vitamin and trace element status of women with disordered eating. American Journal of Clinical Nutrition, 50, 940-944.
22. Nunez, C., Moreiras, O., & Carbajal, A. (1995). Directivas para el tratamiento dietética de los pacientes que tienen anorexia nervosa basado en una evaluación de sus estado nutricional [Guidelines for the dietetic treatment of patients with anorexia nervosa based on an assessment of their nutritional status]. Revista Clinica Espanola, 195, 226-232.
23. Peterson, C.B., & Mitchell, J.E. (1999). Psychosocial and pharmacological treatment of eating disorders: A review of research findings. Journal of Clinical Psychology, 55, 685-697.
24. Rock, C.L., & Curran-Celentano, J. (1994). Nutritional disorder of anorexia nervosa: A review. International Journal of Eating Disorders, 15, 187-203.
25. Rock, C.L., & Vasantharajan, S. (1995). Vitamin status of eating disorder patients: Relationship to clinical indices and effect of treatment. International Journal of Eating Disorders, 18, 257-262.
26. Sharma, S.K., & Dakshinamurti, K. (1994). Effects of serotonergic agents on plasma prolactin levels in pyridoxine-deficient adult male rats. Neurochemical Research, 19, 687-692.
27. Spielberger, C.D., Gorsuch, R.L., & Lushene, R.E. (1970). STAI manual for the State Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press.
28. Strober, M., Pataki, C., Freeman, R., & DeAntonio, M. (1999). No effect of adjunctive fluoxetine on eating behavior or weight phobia during the inpatient treatment of anorexia nervosa: An historical case-control study. Journal of Child and Adolescent Psychopharmacology, 9, 195-201.
29. Sullivan, P.F. (1995). Mortality in anorexia nervosa. American Journal of Psychiatry, 152, 1073-1074.
30. Tollefson, G.D. (1995). Selective serotonin reuptake inhibitors. In A.F. Schatzberg & C.B. Nemeroff (Eds.), Textbook of psychopharmacology (pp. 161-182). Washington, DC: American Psychiatric Press.